1. X
  2. Vanda Pharmaceuticals
Log inSign up
Vanda Pharmaceuticals
214 posts
Image
user avatar
Vanda Pharmaceuticals
@vandapharma
Vanda is a global pharmaceutical company focused on the development of innovative therapies to address unmet medical needs and improve the lives of patients.
Washington DC
vandapharma.com
Joined November 2009
261
Following
1,814
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Jul 16
    Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pu...
    Image
    Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for...
    From prnewswire.com
    76076
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Jul 15
    NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Tr...
    Image
    NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S....
    From prnewswire.com
    1000100
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Jul 9
    Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Mar...
    Image
    Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy...
    From prnewswire.com
    5480548
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    May 27
    Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis
    Image
    Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized...
    From prnewswire.com
    5700570
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    May 8
    Consumers can now order NEREUS™ directly at nereus.us:
    Image
    00:00
    3.5M03.5M
  • Vanda Pharmaceuticals reposted
    user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    1/4 FDA just asked Congress to legalize the exact practices federal courts have ruled unlawful. Page 25 of their FY2027 legislative agenda: delete the 180-day “approve or NOOH” deadline, codify CRLs, and replace real hearings with a weak internal appeal. Full text:
    1.7K01.7K
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    May 1
    Consumers can now order NEREUS™ directly at nereus.us: Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic... prn.to/4cXn7Wr
    Image
    Nereus™ (tradipitant)
    From nereus.us
    7.3M07.3M
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 29
    Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Ps...
    Image
    Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Genera...
    From prnewswire.com
    1.3K01.3K
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Rev...
    Image
    Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would...
    From prnewswire.com
    1.2K01.2K
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    1/4 FDA just asked Congress to legalize the exact practices federal courts have ruled unlawful. Page 25 of their FY2027 legislative agenda: delete the 180-day “approve or NOOH” deadline, codify CRLs, and replace real hearings with a weak internal appeal. Full text:
    1.7K01.7K
    user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    Replying to @vandapharma
    3/4 This proposal would directly nullify Vanda’s hard-won court victories and the landmark Hetlioz jet-lag hearing now underway — the first drug-approval hearing in over 40 years. Bureaucrats trying to legislatively erase accountability is not the MAHA agenda.
    4210421
    user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    4/4 @DrMakaryFDA The statute is clear. Courts are enforcing it. FDA should stop running to Congress to protect unlawful delays and instead deliver the binary decisions the law demands.
    2940294
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    Replying to @vandapharma
    2/4 For years FDA told judges: “Our CRLs, PDUFA delays, and hearing denials fully comply with the statute.” Courts (including D.D.C. 2024 and D.C. Circuit 2025) repeatedly said: No, they don’t. Now FDA wants Congress to rewrite the law to match the violations. That is not
    2310231
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Apr 9
    Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of ...
    Image
    Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the...
    From prnewswire.com
    2890289
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Mar 19
    Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods
    Image
    Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to...
    From prnewswire.com
    735K0735K
  • user avatar
    Vanda Pharmaceuticals
    @vandapharma
    Mar 10
    user avatar
    Mornings with Maria
    @MorningsMaria
    Mar 10
    🚨 FDA approves Neurus by Vanda Pharmaceuticals The new drug is designed to help manage side effects from GLP-1 weight loss medications—potentially helping patients stay on treatment longer. As @mihaelhp puts it: “Everybody wins.”
    Image
    00:00
    1.5K01.5K
Advertisement
Advertisement